Home > Insider Trading > Filing (0001438133-21-000232)

Filing Details

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1438133	Tandem Diabetes Care Inc	TNDM	Surgical & Medical Instruments & Apparatus (3841)	204327508

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1866570	James Leal	C/O Tandem Diabetes Care, Inc. 11075 Roselle Street San Diego CA 92121	Svp, Operations	No	Yes	No	No

Reported Non-Derivative Transactions

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership
Common Stock	Acquisiton	2021-12-27	1,667	$51.50	5,675	No	4	M	Direct
Common Stock	Acquisiton	2021-12-27	239	$82.34	5,914	No	4	M	Direct
Common Stock	Disposition	2021-12-27	540	$150.95	5,374	No	4	S	Direct
Common Stock	Disposition	2021-12-27	1,266	$151.60	4,108	No	4	S	Direct
Common Stock	Disposition	2021-12-27	100	$152.27	4,008	No	4	S	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership
No	4	M	Direct
No	4	M	Direct
No	4	S	Direct
No	4	S	Direct
No	4	S	Direct

Reported Derivative Transactions

Sec. Name	Sec. Type	Acquisiton - Disposition	Date	Amount	Price	Amount - 2	Price - 2
Common Stock	Stock Option	Acquisiton	2021-12-27	1,667	$51.50	1,667	$51.50
Common Stock	Stock Option	Acquisiton	2021-12-27	239	$82.34	239	$82.34

Remaning Holdings	Exercise Date	Expiration Date	Equity Swap Involved	Transaction Form Type	Transaction Code	Nature of Ownership
23,333			No	4	M	Direct
6,909			No	4	M	Direct

Footnotes

Represents shares of common stock received upon exercise of a stock option award.
The shares were sold pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on December 11, 2020.
The price reported reflects the weighted average price per share of multiple transactions with prices per share ranging between $150.25 to $151.21. The Reporting Person undertakes to provide the Securities and Exchange Commission (the "SEC"), the issuer, and any security holder full information regarding the number of shares and the prices at which the shares were sold.
The price reported reflects the weighted average price per share of multiple transactions with prices per share ranging between $151.26 to $152.09.The Reporting Person undertakes to provide the SEC, the issuer, and any security holder full information regarding the number of shares and the prices at which the shares were sold.
The options vested as to twenty-five (25%) of the underlying shares on 2/15/2020, and the remaining shares shall vest in thirty-six (36) equal monthly installments thereafter, subject to the terms of the Tandem Diabetes Care, Inc. 2013 Stock Incentive Plan, as amended, and the agreements related thereto (the "2013 Plan").
The expiration date for these options is 10 years from the date of grant.
The options vested as to twenty-five (25%) of the underlying shares on 5/27/2021, and the remaining shares shall vest in thirty-six (36) equal monthly installments thereafter, subject to the 2013 Plan.